日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Magnetospirillum magneticum Potassium-transporting ATPase A chain (kdpA), partial CSB-YP649705MAAS
CSB-EP649705MAAS
CSB-BP649705MAAS
CSB-MP649705MAAS
CSB-EP649705MAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Magnetospirillum magneticum N (2)-fixation sustaining protein CowN (cowN) CSB-YP649706MAAS
CSB-EP649706MAAS
CSB-BP649706MAAS
CSB-MP649706MAAS
CSB-EP649706MAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Magnetospirillum magneticum Phosphate import ATP-binding protein PstB 1 (pstB1) CSB-YP649707MAAS
CSB-EP649707MAAS
CSB-BP649707MAAS
CSB-MP649707MAAS
CSB-EP649707MAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Magnetospirillum magneticum Probable glycine dehydrogenase [decarboxylating] subunit 1 (gcvPA) CSB-YP649708MAAS
CSB-EP649708MAAS
CSB-BP649708MAAS
CSB-MP649708MAAS
CSB-EP649708MAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Magnetospirillum magneticum Protein RecA (recA) CSB-YP649709MAAS
CSB-EP649709MAAS
CSB-BP649709MAAS
CSB-MP649709MAAS
CSB-EP649709MAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Magnetospirillum magneticum tRNA pseudouridine synthase A (truA) CSB-YP649710MAAS
CSB-EP649710MAAS
CSB-BP649710MAAS
CSB-MP649710MAAS
CSB-EP649710MAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Magnetospirillum magneticum tRNA modification GTPase MnmE (mnmE) CSB-YP649711MAAS
CSB-EP649711MAAS
CSB-BP649711MAAS
CSB-MP649711MAAS
CSB-EP649711MAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Protein shisa-2 (shisa2), partial CSB-YP649712XBE
CSB-EP649712XBE
CSB-BP649712XBE
CSB-MP649712XBE
CSB-EP649712XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Selaginella uncinata Photosystem II reaction center protein Z (psbZ), partial CSB-YP649713SCAC1
CSB-EP649713SCAC1
CSB-BP649713SCAC1
CSB-MP649713SCAC1
CSB-EP649713SCAC1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Selaginella uncinata ATP synthase subunit alpha, chloroplastic (atpA), partial CSB-YP649714SCAC
CSB-EP649714SCAC
CSB-BP649714SCAC
CSB-MP649714SCAC
CSB-EP649714SCAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydomonas reinhardtii Intraflagellar transport protein 57 (IFT57) CSB-YP649715DSJ
CSB-EP649715DSJ
CSB-BP649715DSJ
CSB-MP649715DSJ
CSB-EP649715DSJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tetraodon nigroviridis Sodium channel protein type 4 subunit alpha A (scn4aa), partial CSB-YP649716TCA
CSB-EP649716TCA
CSB-BP649716TCA
CSB-MP649716TCA
CSB-EP649716TCA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Varanus varius Cysteine-rich secretory protein VAR10 CSB-YP649717VEJ
CSB-EP649717VEJ
CSB-BP649717VEJ
CSB-MP649717VEJ
CSB-EP649717VEJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dispholidus typus Cysteine-rich secretory protein DIS3 CSB-YP649718DAAV
CSB-EP649718DAAV
CSB-BP649718DAAV
CSB-MP649718DAAV
CSB-EP649718DAAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Varanus acanthurus Cysteine-rich secretory protein VAR3 CSB-YP649719VAAJ
CSB-EP649719VAAJ
CSB-BP649719VAAJ
CSB-MP649719VAAJ
CSB-EP649719VAAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aedes pseudoscutellaris reovirus Uncharacterized protein VP8 (S8) CSB-YP649720ABAF
CSB-EP649720ABAF
CSB-BP649720ABAF
CSB-MP649720ABAF
CSB-EP649720ABAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Electroneutral sodium bicarbonate exchanger 1 (SLC4A8), partial CSB-YP649721HU
CSB-EP649721HU
CSB-BP649721HU
CSB-MP649721HU
CSB-EP649721HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Avian metapneumovirus Phosphoprotein CSB-YP649722ABAG
CSB-EP649722ABAG
CSB-BP649722ABAG
CSB-MP649722ABAG
CSB-EP649722ABAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosospira multiformis Ribosomal RNA small subunit methyltransferase G (rsmG) CSB-YP649723NAAH
CSB-EP649723NAAH
CSB-BP649723NAAH
CSB-MP649723NAAH
CSB-EP649723NAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nitrosospira multiformis Putative arginyl-tRNA--protein transferase (ate) CSB-YP649724NAAH
CSB-EP649724NAAH
CSB-BP649724NAAH
CSB-MP649724NAAH
CSB-EP649724NAAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×